Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

FANCE (Fanconi anemia, complementation group E)

Identity

Other namesFACE
FAE
HGNC FANCE
Location 6p21
Local_order located between the 60S ribosomal protein RPL10Aand a ZNF127 like protein

DNA/RNA

Description the gene spans 15 kb and contains 10 exons;1611 bp open reading frame

Protein

Description 536 amino acids, 60 kDa; contains two potential nuclear localization signals
Function part of the FA complex with FANCA, FANCC, FANCF, and FANCG. ; this complex is only found in the nucleus.
  • FANCA and FANCG form a complex in the cytoplasm, through a N-term FANCA (involving the nuclear localization signal) - FANCG interaction; FANCC join the complex; phosphorylation of FANCA would induce its translocation into the nucleus.This FA complex translocates into the nucleus, where FANCE and FANCF are present; FANCE and FANCF join the complex. The FA complex subsequently interacts with FANCD2 by monoubiquitination of FANCD2 during S phase or following DNA damage. Activated (ubiquinated ) FANCD2, downstream in the FA pathway, will then interact with other proteins involved in DNA repair, possibly BRCA1; after DNA repair, FANCD2 return to the non-ubiquinated form.
    • Homology no known homology

    Implicated in

    Entity BEGIN_ENTITY Fanconi anaemia (FA); FANCE is implicated in the FA complementation group E; it represents about 2% of FA cases
    Disease Fanconi anaemia is a chromosome instability syndrome/cancer prone disease (at risk of leukaemia)
    Prognosis Fanconi anaemia's prognosis is poor; mean survival is 20 years (depending on mutation, treatment): patients die of bone marrow failure (infections, haemorrhages), leukaemia, or androgen therapy related liver tumours
  • It has recently been shown that significant phenotypic differences were found between the various complementation groups. Patients from the rare groups FA-D, FA-E, and FA-F had somatic abnormalities more frequently.
    • Cytogenetics spontaneous,chromatid/chromosome breaks; increased rate of breaks compared to control, when induced by breaking agent
      

    External links

    Nomenclature
    HGNCFANCE   3586
    Entrez_GeneFANCE  2178  Fanconi anemia, complementation group E
    Cards
    AtlasFANCEID293
    GeneCardsFANCE
    EnsemblFANCE [Search_View]   ENSG00000112039 [Gene_View]
    GenatlasFANCE
    GeneLynxFANCE
    eGenomeFANCE
    euGene2178
    Genomic and cartography
    GoldenPathFANCE  -  6p21   chr6:35528116-35542859 +  6p22-p21   [Description]    (hg18-Mar_2006)
    EnsemblFANCE - 6p22-p21 [CytoView]
    NCBIMapview
    OMIMDisease map [OMIM]
    HomoloGeneFANCE
    Gene and transcription
    GenbankAF265210 [ ENTREZ ]
    GenbankAK292522 [ ENTREZ ]
    GenbankAK312617 [ ENTREZ ]
    GenbankBC046359 [ ENTREZ ]
    GenbankCR605350 [ ENTREZ ]
    RefSeqNM_021922 [ SRS ]    NM_021922 [ ENTREZ ]
    RefSeqAC_000049 [ SRS ]    AC_000049 [ ENTREZ ]
    RefSeqAC_000138 [ SRS ]    AC_000138 [ ENTREZ ]
    RefSeqNC_000006 [ SRS ]    NC_000006 [ ENTREZ ]
    RefSeqNT_007592 [ SRS ]    NT_007592 [ ENTREZ ]
    RefSeqNW_001838980 [ SRS ]    NW_001838980 [ ENTREZ ]
    RefSeqNW_923073 [ SRS ]    NW_923073 [ ENTREZ ]
    AceViewFANCE AceView - NCBI
    UnigeneHs.302003 [ SRS ]    Hs.302003 [ NCBI ]     HS302003 [ spliceNest ]
    Fast-db8622 (alternative variants)
    Protein : pattern, domain, 3D structure
    SwissProtQ9HB96 [ SRS]    Q9HB96 [ EXPASY ]     Q9HB96 [ INTERPRO ]     Q9HB96 [ UNIPROT ]
    CluSTrQ9HB96
    BlocksQ9HB96
    PDB2ILR [ SRS ]    2ILR [ PdbSum ],   2ILR [ IMB ]   2ILR [ RSDB ]
    HPRD02943
    Protein Interaction databases
    DIPQ9HB96
    IntActQ9HB96
    Polymorphism : SNP, mutations, diseases
    OMIM600901    [ map ]   
    GENECLINICS600901
    SNPFANCE [dbSNP-NCBI]  
    SNPNM_021922 [SNP-NCI]  
    SNPFANCE [GeneSNPs - Utah]  FANCE] [HGBASE - SRS]
    HAPMAPFANCE [HAPMAP]  
    COSMICFANCE [Somatic mutation (COSMIC-CGP-Sanger)]  
    HGMDFANCE
    General knowledge
    Family BrowserFANCE [UCSC Family Browser]
    SOURCENM_021922
    SMDHs.302003
    SAGEHs.302003
    GOmolecular_function [Amigo]  molecular_function
    GOprotein binding [Amigo]  protein binding
    GOnucleus [Amigo]  nucleus
    GODNA repair [Amigo]  DNA repair
    BIOCARTARole of BRCA1, BRCA2 and ATR in Cancer Susceptibility    [Genes]
    BIOCARTABRCA1-dependent Ub-ligase activity    [Genes]
    PubGeneFANCE
    TreeFamFANCE
    CTD2178 [Comparative ToxicoGenomics Database]
    Other databases
    Other databaseFanconi anemia mutation database
    Probes
    ProbeCancer Cytogenetics (Bari)
    ProbeFANCE Related clones (RZPD - Berlin)
    PubMed
    PubMed23 Pubmed reference(s) in LocusLink

    Bibliography

    Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
    Garcia-Higuera I, Kuang Y, Nˆ§f D, Wasik J, D'Andrea AD
    Molecular and cellular biology. 1999 ; 19 (7) : 4866-4873.
    PMID 10373536
     
    Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, Mathew CG
    Blood. 2000 ; 96 (13) : 4064-4070.
    PMID 11110674
     
    Isolation of a cDNA representing the Fanconi anemia complementation group E gene.
    de Winter JP, Lˆ©veillˆ© F, van Berkel CG, Rooimans MA, van Der Weel L, Steltenpool J, Demuth I, Morgan NV, Alon N, Bosnoyan-Collins L, Lightfoot J, Leegwater PA, Waisfisz Q, Komatsu K, Arwert F, Pronk JC, Mathew CG, Digweed M, Buchwald M, Joenje H
    American journal of human genetics. 2000 ; 67 (5) : 1306-1308.
    PMID 11001585
     
    Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
    Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD
    Molecular cell. 2001 ; 7 (2) : 249-262.
    PMID 11239454
     
    Fanconi anemia and DNA repair.
    Grompe M, D'Andrea A
    Human molecular genetics. 2001 ; 10 (20) : 2253-2259.
    PMID 11673408
     
    Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway.
    Medhurst AL, Huber PA, Waisfisz Q, de Winter JP, Mathew CG
    Human molecular genetics. 2001 ; 10 (4) : 423-429.
    PMID 11157805
     
    Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
    Qiao F, Moss A, Kupfer GM
    The Journal of biological chemistry. 2001 ; 276 (26) : 23391-23396.
    PMID 11297559
     
    Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T, Nakahata T
    International journal of hematology. 2001 ; 74 (1) : 33-41.
    PMID 11530803
     
    Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia.
    Callˆ©n E, Samper E, Ramˆ‚rez MJ, Creus A, Marcos R, Ortega JJ, Olivˆ© T, Badell I, Blasco MA, Surrallˆ©s J
    Human molecular genetics. 2002 ; 11 (4) : 439-444.
    PMID 11854176
     
    REVIEW articlesautomatic search in PubMed
    Last year publicationsautomatic search in PubMed

    Search in all EBI   NCBI

    Contributor(s)

    Written06-2002Jean-Loup Huret

    Citation

    This paper should be referenced as such :
    Huret JL . FANCE (Fanconi anemia, complementation group E). Atlas Genet Cytogenet Oncol Haematol. June 2002 .
    URL : http://AtlasGeneticsOncology.org/Genes/FANCEID293.html

    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Mon Aug 11 21:13:48 2008

    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    j.l.huret@chu-poitiers.fr.